144 related articles for article (PubMed ID: 25801931)
1. Pseudosaccharin amines as potent and selective KV1.5 blockers.
Lloyd J; Finlay HJ; Kover A; Johnson J; Pi Z; Jiang J; Neels J; Cavallaro C; Wexler R; Conder ML; Shi H; Li D; Sun H; Chimalakonda A; Huang C; Salvati M; Levesque P
Bioorg Med Chem Lett; 2015 Nov; 25(21):4983-4986. PubMed ID: 25801931
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitors.
Johnson JA; Xu N; Jeon Y; Finlay HJ; Kover A; Conder ML; Sun H; Li D; Levesque P; Hsueh MM; Harper TW; Wexler RR; Lloyd J
Bioorg Med Chem Lett; 2014 Jul; 24(14):3018-22. PubMed ID: 24881565
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation.
Blass BE; Coburn K; Lee W; Fairweather N; Fluxe A; Wu S; Janusz JM; Murawsky M; Fadayel GM; Fang B; Hare M; Ridgeway J; White R; Jackson C; Djandjighian L; Hedges R; Wireko FC; Ritter AL
Bioorg Med Chem Lett; 2006 Sep; 16(17):4629-32. PubMed ID: 16793267
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers.
Lloyd J; Finlay HJ; Vacarro W; Hyunh T; Kover A; Bhandaru R; Yan L; Atwal K; Conder ML; Jenkins-West T; Shi H; Huang C; Li D; Sun H; Levesque P
Bioorg Med Chem Lett; 2010 Feb; 20(4):1436-9. PubMed ID: 20097068
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists.
Lloyd J; Finlay HJ; Atwal K; Kover A; Prol J; Yan L; Bhandaru R; Vaccaro W; Huynh T; Huang CS; Conder M; Jenkins-West T; Sun H; Li D; Levesque P
Bioorg Med Chem Lett; 2009 Sep; 19(18):5469-73. PubMed ID: 19665893
[TBL] [Abstract][Full Text] [Related]
6. Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel.
Gross MF; Beaudoin S; McNaughton-Smith G; Amato GS; Castle NA; Huang C; Zou A; Yu W
Bioorg Med Chem Lett; 2007 May; 17(10):2849-53. PubMed ID: 17350840
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors.
Zhao L; Yang Q; Tang Y; You Q; Guo X
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):462-471. PubMed ID: 35012386
[TBL] [Abstract][Full Text] [Related]
8. Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel.
Olsson RI; Jacobson I; Iliefski T; Boström J; Davidsson Ö; Fjellström O; Björe A; Olsson C; Sundell J; Gran U; Gyll J; Malmberg J; Hidestål O; Emtenäs H; Svensson T; Yuan ZQ; Strandlund G; Åstrand A; Lindhardt E; Linhardt G; Forsström E; Högberg Å; Persson F; Andersson B; Rönnborg A; Löfberg B
Bioorg Med Chem Lett; 2014 Mar; 24(5):1269-73. PubMed ID: 24513046
[TBL] [Abstract][Full Text] [Related]
9. Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approach.
Kajanus J; Jacobson I; Åstrand A; Olsson RI; Gran U; Björe A; Fjellström O; Davidsson Ö; Emtenäs H; Dahlén A; Löfberg B; Yuan ZQ; Sundell J; Cassel J; Gyll J; Iliefski T; Högberg Å; Lindhardt E; Malmberg J
Bioorg Med Chem Lett; 2016 Apr; 26(8):2023-9. PubMed ID: 26965854
[TBL] [Abstract][Full Text] [Related]
10. Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.
Guo X; Yang Q; Xu J; Zhang L; Chu H; Yu P; Zhu Y; Wei J; Chen W; Zhang Y; Zhang X; Sun H; Tang Y; You Q
Bioorg Med Chem; 2013 Nov; 21(21):6466-76. PubMed ID: 24071446
[TBL] [Abstract][Full Text] [Related]
11. Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channel.
Gross MF; Castle NA; Zou A; Wickenden AD; Yu W; Spear KL
Bioorg Med Chem Lett; 2009 Jun; 19(11):3063-6. PubMed ID: 19398199
[TBL] [Abstract][Full Text] [Related]
12. Kv1.5 blockers for the treatment of atrial fibrillation: approaches to optimization of potency and selectivity and translation to in vivo pharmacology.
Bilodeau MT; Trotter BW
Curr Top Med Chem; 2009; 9(5):436-51. PubMed ID: 19519460
[TBL] [Abstract][Full Text] [Related]
13. Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
Jackson CM; Blass B; Coburn K; Djandjighian L; Fadayel G; Fluxe AJ; Hodson SJ; Janusz JM; Murawsky M; Ridgeway JM; White RE; Wu S
Bioorg Med Chem Lett; 2007 Jan; 17(1):282-4. PubMed ID: 17095219
[TBL] [Abstract][Full Text] [Related]
14. Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers.
Wu S; Fluxe A; Janusz JM; Sheffer JB; Browning G; Blass B; Cobum K; Hedges R; Murawsky M; Fang B; Fadayel GM; Hare M; Djandjighian L
Bioorg Med Chem Lett; 2006 Nov; 16(22):5859-63. PubMed ID: 16942874
[TBL] [Abstract][Full Text] [Related]
15. Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers.
Fluxe A; Wu S; Sheffer JB; Janusz JM; Murawsky M; Fadayel GM; Fang B; Hare M; Djandjighian L
Bioorg Med Chem Lett; 2006 Nov; 16(22):5855-8. PubMed ID: 16942878
[TBL] [Abstract][Full Text] [Related]
16. I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.
Tamargo J; Caballero R; Gómez R; Delpón E
Expert Opin Investig Drugs; 2009 Apr; 18(4):399-416. PubMed ID: 19335273
[TBL] [Abstract][Full Text] [Related]
17. Structure-based virtual screening and electrophysiological evaluation of new chemotypes of K(v)1.5 channel blockers.
Yang Q; Fedida D; Xu H; Wang B; Du L; Wang X; Li M; You Q
ChemMedChem; 2010 Aug; 5(8):1353-8. PubMed ID: 20540065
[TBL] [Abstract][Full Text] [Related]
18. Benzopyran sulfonamides as KV1.5 potassium channel blockers.
Lloyd J; Atwal KS; Finlay HJ; Nyman M; Huynh T; Bhandaru R; Kover A; Schmidt J; Vaccaro W; Conder ML; Jenkins-West T; Levesque P
Bioorg Med Chem Lett; 2007 Jun; 17(12):3271-5. PubMed ID: 17462888
[TBL] [Abstract][Full Text] [Related]
19. Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides.
Nanda KK; Nolt MB; Cato MJ; Kane SA; Kiss L; Spencer RH; Wang J; Lynch JJ; Regan CP; Stump GL; Li B; White R; Yeh S; Bogusky MJ; Bilodeau MT; Dinsmore CJ; Lindsley CW; Hartman GD; Wolkenberg SE; Trotter BW
Bioorg Med Chem Lett; 2006 Nov; 16(22):5897-901. PubMed ID: 16949818
[TBL] [Abstract][Full Text] [Related]
20. Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.
Finlay HJ; Jiang J; Caringal Y; Kover A; Conder ML; Xing D; Levesque P; Harper T; Hsueh MM; Atwal K; Blanar M; Wexler R; Lloyd J
Bioorg Med Chem Lett; 2013 Mar; 23(6):1743-7. PubMed ID: 23414837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
